“…Recently, significant concerns have focused on the non-viral vector since they have the potential to be administered repeatedly with minimal host immune response, targetable, stable in storage and easy to produce in large quantities [1,2]. However, non-viral vectors should overcome many barriers such as low efficiency in delivery to target cells, escape from endosome, internalization into the nucleus, transcription and translation of DNA.…”